A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line
Authors:
- 12 February 2003
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 104 (6) , 709-715
Abstract
Telomerase activity is detectable in most human tumors but not in most normal somatic cells or tissues. Telomerase inhibition has, therefore, been proposed as a novel and potentially selective strategy for antitumor therapy. In the present study, we found that platinum compounds, including cisplatin [cis‐diamminedichloro‐platinum (II)], strongly inhibited the activity of partially purified rat telomerase. Among the agents tested, 2,3‐dibromosuccinato [2‐(methylaminomethyl)pyridine]platinum (II) (compound E) exhibited the strongest inhibition, with an median inhibitory concentration (IC50) of 0.8 μM. The mode of inhibition was noncompetitive with either dNTPs or TS (first) primer, with Ki values estimated to be 2.3 or 3.9 μM for varied TS primer or dNTPs, respectively. Notably, cisplatin also inhibited the telomerase activity, with an IC50 of 2.0 μM. Again, the mode of inhibition was noncompetitive, with Ki values estimated as 7.3 or 8.1 μM. Preincubation of TS primer with compound E did not affect the telomerase inhibition, whereas preincubation with cisplatin caused remarkable enhancement. Treatment of a human hepatoma cell line HepG2 with a low concentration of compound E gradually reduced the telomere length, indicating that this compound was able to inhibit telomerase in living cells as well as in vitro.Keywords
This publication has 40 references indexed in Scilit:
- Isothiazolone Derivatives Selectively Inhibit Telomerase from Human and Rat Cancer Cells in VitroBiochemistry, 1999
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Structure and function of telomeresNature, 1991
- Sequence‐dependent Termination of Mammalian DNA Polymerase Reaction by a New Platinum Compound, (–)‐(R)‐2‐Aminomethylpyrrolidine(1,1‐cyclobutane‐dicarboxylato)‐2‐platinum(II) MonohydrateJapanese Journal of Cancer Research, 1991
- Telomere loss: mitotic clock or genetic time bomb?Mutation Research/DNAging, 1991
- The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeatsCell, 1989
- A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesisNature, 1989
- Identification of a specific telomere terminal transferase activity in tetrahymena extractsCell, 1985
- Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).Proceedings of the National Academy of Sciences, 1985
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985